SAO Equity Snapshot

BIIB34 Weekly Equity Report

Biogen Inc.

Interactive chart JSON snapshot
Latest Close 162.1 BRL 12 Jun 2026
1W Return 0.0% latest completed week
4W Return -0.1% short-term follow-through
12W Return -0.3% quarterly tape
Trend Breadth 57.7% 30 of 52 weeks active
Volume Ratio - vs 13-week average
Company Brief

What the company does

Biogen Inc. discovers, develops, manufactures, and delivers therapies in the United States, Europe, Germany, Asia, and internationally. The company provides TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, and TYSABRI for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; SKYCLARYS to treat Friedreich's Ataxia; QALSODY for treating amyotrophic lateral sclerosis; FUMADERM to treat plaque psoriasis; BENEPALI, an etanercept biosimilar referencing ENBREL; IMRALDI, an adalimumab biosimilar referencing HUMIRA; FLIXABI, an infliximab biosimilar referencing REMICADE. It offers LEQEMBI for the treatment of Alzheimer's disease; ZURZUVAE for the treatment of postpartum depression; RITUXAN to treat non-Hodgkin's lymphoma, chronic lymphocytic leukemia (CLL), rheumatoid …

Snapshot

What the weekly tape is saying

BIIB34 closed the latest completed week at 162.1 BRL. The 4-week return is -0.1% and the 12-week return is -0.3%. Trend Signal is inactive, Market Dynamics is -0.52. Setup signature: Balanced read with a 48/100 composite read.

Trend Signal Inactive
Market Dynamics No fresh buy
Price vs Trend 1.3%
Volume -
Setup Cockpit

A compressed read of the whole setup

The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.

Composite setup radar

Scoreboard

Trend 32 Persistence of active Trend Signal over the last year and current streak.
Momentum 49 Blend of 4-week and 12-week follow-through.
Dynamics 41 Latest Market Dynamics and whether pressure has improved over four weeks.
Relative Strength 93 Relative leadership and short-term RS change.
Volume 0 Participation compared with the 13-week volume baseline.
Risk Control 75 Drawdown and recent weekly volatility pressure.

16-week signal tape

27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun
Weekly return bar Trend Signal dot Positive Market Dynamics dot
Price Action

Price, Trend Line, and Fair Value

Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.

52-week price path

Price Trend Line Fair Value

Price map

Trend Line
160.1 BRL
Vs Trend Line
1.3%
Fair Value
167.5 BRL
Vs Fair Value
-3.2%
52W High
172.3 BRL
52W Low
113.6 BRL
Drawdown
-5.9%
Range Position
82.6%
Momentum

Returns and trend persistence

Return windows separate the latest week from short-term and medium-term follow-through.

Return windows

1W 0.0%
4W -0.1%
12W -0.3%
26W 4.0%
52W 30.4%

Trend read

Active Streak
0 weeks
52W Active Weeks
30
52W Active Breadth
57.7%
Sector Scope
BR Healthcare
Sector Rank
42 of 80
Sector Percentile
48.1%
Peer Context

Sector and industry pulse

Peer breadth helps separate a stock-specific move from a broader group rotation.

Market Dynamics

Pressure, Relative Strength, and expectation

Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.

Dynamics path

Market Dynamics Relative Strength

Signal state

Market Dynamics
-0.52
4W MD Change
-0.2%
Relative Strength
3.99
4W RS Change
390.6%
Expectation
Negative
Probability
30.16%
Volume

Participation and confirmation

Volume tells us whether the latest weekly move is being confirmed by unusual participation.

52-week volume profile

Volume map

Latest Volume
0
13W Average
87
52W Average
106
Vs 13W
-
Vs 52W
-
Risk Anatomy

Volatility, downside weeks, and return shape

A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.

26-week return distribution

Risk map

13W Volatility
3.0%
52W Volatility
4.0%
Upside Weeks
26
Downside Weeks
18
Downside Breadth
34.6%
Avg Gain / Loss
3.6% / -3.5%
Context

Classification, opportunities, risks, and watch points

Top-level read across company classification, constructive evidence, caution points, and the next things that matter.

Classification

Exchange
SAO
Country
BR
Sector
Healthcare
Industry
Drug Manufacturers - General
Currency
BRL
Market Cap
144.2B

Opportunity signals

  • Price is above the Trend Line, keeping the weekly tape constructive.

Risk signals

  • Trend Signal is inactive, so price action has not confirmed a constructive regime.
  • Price is below Fair Value, so the market is still discounting the latest tape.
  • Market Dynamics is negative, which weakens the current setup.

Watch next

  • Trend Line remains the key weekly regime level.
  • Market Dynamics is the pressure gauge to monitor for confirmation or fade.
Weekly Tape

Recent completed weeks

The latest weekly rows behind the report snapshot.

Week Close Return Trend Fair Value MD RS Volume Signal
12 Jun 2026 162.1 BRL 0.0% 160.1 BRL 167.5 BRL -0.52 3.99 0 Off
5 Jun 2026 162.1 BRL 0.0% 159.5 BRL 168.0 BRL -0.56 5.38 0 Off
29 May 2026 162.1 BRL 3.1% 158.8 BRL 168.6 BRL -0.58 2.62 434 Off
22 May 2026 157.3 BRL -3.1% 158.0 BRL 169.1 BRL -0.65 -1.69 2 Off
15 May 2026 162.2 BRL 2.6% 157.2 BRL 169.7 BRL -0.52 0.81 40 On
8 May 2026 158.1 BRL -1.1% 156.1 BRL 170.3 BRL -0.76 -5.21 120 Off
1 May 2026 159.8 BRL 4.3% 155.3 BRL 171.0 BRL -0.89 -5.74 41 Off
24 Apr 2026 153.2 BRL 2.9% 154.6 BRL 171.6 BRL -0.94 -11.24 233 Off
17 Apr 2026 148.9 BRL -0.5% 153.7 BRL 172.3 BRL -0.93 -15.98 4 On
10 Apr 2026 149.7 BRL -7.9% 153.0 BRL 172.8 BRL -0.68 -16.44 256 On
3 Apr 2026 162.6 BRL 0.0% 152.4 BRL 173.3 BRL -0.58 -5.00 0 On
27 Mar 2026 162.6 BRL 0.0% 151.2 BRL 173.8 BRL -0.55 -1.80 0 On
20 Mar 2026 162.6 BRL 0.0% 149.8 BRL 174.3 BRL -0.53 0.87 0 On
13 Mar 2026 162.6 BRL -1.3% 148.6 BRL 174.7 BRL -0.41 -0.20 6 On